The combination treatment was found to be more effective at improving the insulin secretion-sensitivity index (IS-SI, which was derived by applying the concept of the DI to measurements obtained during the 2-h OGTT) in pre-diabetic women with PCOS [20]. The gene discussed is INS; the disease is polycystic ovary syndrome.